Cigna Corp. (CI) Shares Rose While Friess Associates LLC Has Increased by $3.53 Million Its Holding

February 15, 2018 - By Ivan Hodges

Investors sentiment is 0.96 in Q3 2017. Its the same as in 2017Q2. It is flat, as 47 investors sold CI shares while 249 reduced holdings. only 72 funds opened positions while 212 raised stakes. 206.32 million shares or 5.35% less from 217.98 million shares in 2017Q2 were reported. Northcoast Asset Management Ltd holds 1.64% of its portfolio in Cigna Corporation (NYSE:CI) for 74,466 shares. Dimensional Fund Advsr LP stated it has 1.43 million shares. Moreover, Rhumbline Advisers has 0.19% invested in Cigna Corporation (NYSE:CI). Washington Trust has invested 0.02% in Cigna Corporation (NYSE:CI). Atlantic Gp Ltd Liability Com reported 0.4% stake. Burney accumulated 21,075 shares. Bp Public Lc owns 32,000 shares for 0.21% of their portfolio. Advantus Capital Mgmt Inc, a Minnesota-based fund reported 25,421 shares. Moreover, Cornerstone Mngmt Holding Limited Liability has 0.29% invested in Cigna Corporation (NYSE:CI) for 196,209 shares. Comerica State Bank has invested 0.09% of its portfolio in Cigna Corporation (NYSE:CI). West Oak Limited Liability Corporation stated it has 0.01% in Cigna Corporation (NYSE:CI). Sumitomo Mitsui Asset Management Limited holds 0.06% or 19,690 shares. Founders Capital Mgmt Ltd Liability stated it has 0.2% in Cigna Corporation (NYSE:CI). 1832 Asset L P, a Ontario – Canada-based fund reported 2,097 shares. Regions Fincl holds 18,664 shares or 0.04% of its portfolio.

Since August 16, 2017, it had 0 buys, and 8 insider sales for $8.84 million activity. ZOLLARS WILLIAM D also sold $230,662 worth of Cigna Corporation (NYSE:CI) shares. Bacus Lisa R also sold $402,366 worth of Cigna Corporation (NYSE:CI) on Wednesday, August 16. Another trade for 400 shares valued at $85,184 was made by HENNEY JANE E MD on Friday, January 12. 28,037 shares were sold by MURABITO JOHN M, worth $5.77M. Shares for $1.29 million were sold by ZARCONE DONNA F.

Friess Associates Llc increased its stake in Cigna Corp. (CI) by 23.65% based on its latest 2017Q3 regulatory filing with the SEC. Friess Associates Llc bought 19,000 shares as the company’s stock rose 11.09% with the market. The institutional investor held 99,324 shares of the medical specialities company at the end of 2017Q3, valued at $18.57M, up from 80,324 at the end of the previous reported quarter. Friess Associates Llc who had been investing in Cigna Corp. for a number of months, seems to be bullish on the $46.72B market cap company. The stock decreased 2.08% or $4.07 during the last trading session, reaching $191.48. About 1.20 million shares traded. Cigna Corporation (NYSE:CI) has risen 23.57% since February 15, 2017 and is uptrending. It has outperformed by 6.87% the S&P500.

Another recent and important Cigna Corporation (NYSE:CI) news was published by which published an article titled: “Cigna Increases Minimum Wage to $16 an Hour and Further Accelerates …” on January 31, 2018.

Cigna Corporation (NYSE:CI) Ratings Coverage

Among 20 analysts covering CIGNA (NYSE:CI), 16 have Buy rating, 0 Sell and 4 Hold. Therefore 80% are positive. CIGNA had 59 analyst reports since July 27, 2015 according to SRatingsIntel. The stock of Cigna Corporation (NYSE:CI) earned “Buy” rating by Credit Suisse on Friday, November 3. As per Wednesday, June 7, the company rating was maintained by Jefferies. The firm has “Buy” rating given on Friday, August 4 by Jefferies. RBC Capital Markets maintained the stock with “Buy” rating in Friday, November 3 report. The firm has “Outperform” rating given on Monday, May 8 by RBC Capital Markets. The stock of Cigna Corporation (NYSE:CI) earned “Buy” rating by Deutsche Bank on Thursday, July 13. Goldman Sachs initiated the stock with “Hold” rating in Wednesday, January 3 report. Morgan Stanley maintained the stock with “Overweight” rating in Friday, November 3 report. The rating was maintained by RBC Capital Markets on Thursday, June 22 with “Outperform”. On Friday, August 4 the stock rating was maintained by Oppenheimer with “Buy”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.